The use of the Ki-67 in deciding which patients with HR+ breast cancer can safely avoid chemotherapy

(1:21)

Ki67, what is it and why is it controversial?

(2:31)

Ki-67: Explained!!! #Medschooldiscussion

(3:53)

Dr. Ellis Discusses the Cell-Proliferation Marker Ki67

(50)

Ki67 helps chromosomes keep their distance

(2:52)

Dr. Nielsen on the Clinical Utility of Ki67 in Breast Cancer

(49)

Dr. Nielsen on the Pros and Cons of the Ki67 Assay in Breast Cancer

(1:19)

Imp. Announcement: Kal Ki Live Miss Mat Karna

(2:34)

Ki-67 index after neoadjuvant ET as a prognostic biomarker for HR+/HER2- early breast cancer

(6:9)

Dr. Ellis Discusses Ki67 as a Treatment Monitoring Biomarker

(1:52)

Dr. Nielsen on the Challenges of Using Ki67 as a Tool in Breast Cancer

(1:1econd)

Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes...

(2:25)

The use of Ki-67, a proliferation marker, for guiding treatment decisions in breast cancer patients

(1:12)

LUMINA results: Women with low levels of the Ki67 biomarker can avoid outcomes related to RT

(2:7)

Dr. Ellis on Measuring Endocrine Therapy Efficacy With Ki67

(55)

Rejunex CD3 Tablet Use Composition Dose Side Effects and Price (in Hindi) | Multivitamin

(5:40)

ProArt P16: A Game-Changer for Creators \u0026 Coders!

(12:31)

p53 Tumour Suppressor and MDM2

(3:34)

Dr. Goncalves Discusses the Development of a Standardized Ki-67 Assay

(3:17)

PerELISA: de-escalated therapy for HR+/HER2+ BC with Ki67 response following 2-week letrozole

(1:17)

The Value of MIPI and Ki-67 in Mantle Cell Lymphoma

(2:47)

Role of Ki 67 Index in Grading of MTC

(1:38)

Dr. Nielsen Discusses Using a Ki67 Assay in Breast Cancer

(1:29)